))
DME/Retina Edition: Top Headlines for Week of September 9, 2024
Manage episode 439584622 series 3560281
المحتوى المقدم من Healio. يتم تحميل جميع محتويات البودكاست بما في ذلك الحلقات والرسومات وأوصاف البودكاست وتقديمها مباشرة بواسطة Healio أو شريك منصة البودكاست الخاص بهم. إذا كنت تعتقد أن شخصًا ما يستخدم عملك المحمي بحقوق الطبع والنشر دون إذنك، فيمكنك اتباع العملية الموضحة هنا https://ar.player.fm/legal.
In this edition, enrollment and dosing complete in phase 1 trial of AIV007, popular benchmarks in clinical practice guidelines and more. Read the full coverage here:
Enrollment, dosing complete in phase 1 trial of AIV007 for AMD, diabetic macular edema
OCT, visual acuity popular benchmarks in clinical practice guidelines for DME
First patient dosed in phase 2 trial of EC-104 implant for diabetic macular edema
OCS-01 eye drop for DME in second stage of phase 3 trial
Q&A: Susvimo delivers immediate durability after implantation in wet AMD
References:
Crawford C. Update on OCS-01: A novel topical drop for DME in phase 3 trials. Presented at: Clinical Trials at the Summit; June 8, 2024; Park City, Utah.
Healio Interviews
McAllister M, et al. Assessing the strength of clinical practice guidelines for managing diabetic macular edema — A systematic literature review. Presented at: American Society of Retina Specialists annual meeting; July 17-20, 2024; Stockholm.
118 حلقات
مشاركة
